KIOXIA AiSAQ Technology Integrated into Milvus Vector Database

First announced early this year, KIOXIA's AiSAQ open-source software technology increases vector scalability by storing all RAG database elements on SSDs. It provides tuning options to prioritize ...
Seeking Alpha

Regenxbio's Vector Technology Will Change Gene Therapy

Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...
Yahoo Finance

U.S. FDA Grants Platform Technology Designation to the Viral Vector Used in SRP-9003, Sarepta’s Investigational Gene Therapy for the Treatment of Limb Girdle Muscular ...

CAMBRIDGE, Mass., June 04, 2025--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the rAAVrh74 viral vector ...
GEN

Vector Production Would Benefit from Purpose-Built Processing Technology

Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...

KIOXIA AiSAQ(TM) Technology Integrated into Milvus Vector Database

With KIOXIA AiSAQ (TM) technology now integrated into Milvus, Kioxia and the open-source community are enabling a new class of scalable, cost-efficient vector search solutions designed to meet the ...